ENTvantage Dx Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 14

ENTvantage Dx General Information

Description

Manufacturer of in-office diagnostic test kits intended to determine the cause of ear, nose, and throat illnesses. The company's product qualitatively identifies the major bacterial sinusitis pathogens and provides differentiation from viral sinusitis infections, enabling physicians to prescribe antibiotic treatment for patients who have bacterial sinusitis, and reducing the unnecessary prescription of antibiotics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4200 Marathon Boulevard
  • Suite 200
  • Austin, TX 78756
  • United States
+1 (800)
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 4200 Marathon Boulevard
  • Suite 200
  • Austin, TX 78756
  • United States
+1 (800)

ENTvantage Dx Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ENTvantage Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 13-Feb-2023 Completed Generating Revenue
10. Later Stage VC 20-Jan-2021 Completed Generating Revenue
9. Grant 01-Feb-2020 Completed Generating Revenue
8. Later Stage VC 20-Aug-2019 Completed Generating Revenue
7. Later Stage VC 01-Oct-2018 Completed Generating Revenue
6. Early Stage VC (Series B) 03-Nov-2017 Completed Generating Revenue
5. Early Stage VC (Series A) 01-Oct-2016 Completed Generating Revenue
4. Grant 14-Jan-2016 Completed Generating Revenue
3. Accelerator/Incubator 10-Dec-2014 Completed Generating Revenue
2. Grant 02-Apr-2014 $1K Completed Generating Revenue
To view ENTvantage Dx’s complete valuation and funding history, request access »

ENTvantage Dx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view ENTvantage Dx’s complete cap table history, request access »

ENTvantage Dx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of in-office diagnostic test kits intended to determine the cause of ear, nose, and throat illnesses. The c
Diagnostic Equipment
Austin, TX
4 As of 2024

Uppsala, Sweden
 

Braintree, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ENTvantage Dx Competitors (2)

One of ENTvantage Dx’s 2 competitors is Q-linea, a Formerly VC-backed company based in Uppsala, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Q-linea Formerly VC-backed Uppsala, Sweden
Neurent Medical Venture Capital-Backed Braintree, MA
You’re viewing 2 of 2 competitors. Get the full list »

ENTvantage Dx Patents

ENTvantage Dx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018244352-A1 Devices and methods for diagnosis of sinusitis Inactive 28-Mar-2017
JP-2020515365-A Sinusitis diagnostic device and method Pending 28-Mar-2017
EP-3600066-A1 Devices and methods for diagnosis of sinusitis Inactive 28-Mar-2017
EP-3600066-A4 Devices and methods for diagnosis of sinusitis Inactive 28-Mar-2017
CA-3057853-A1 Devices and methods for diagnosis of sinusitis Pending 28-Mar-2017 A61B10/0045
To view ENTvantage Dx’s complete patent history, request access »

ENTvantage Dx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ENTvantage Dx Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
HSC Next Accelerator/Incubator
Capital Factory Accelerator/Incubator Minority
Denniston Family Office Family Office Minority
Sea Purity Investments Family Office Minority
National Institutes of Health Government
You’re viewing 5 of 14 investors. Get the full list »

ENTvantage Dx FAQs

  • When was ENTvantage Dx founded?

    ENTvantage Dx was founded in 2013.

  • Where is ENTvantage Dx headquartered?

    ENTvantage Dx is headquartered in Austin, TX.

  • What is the size of ENTvantage Dx?

    ENTvantage Dx has 4 total employees.

  • What industry is ENTvantage Dx in?

    ENTvantage Dx’s primary industry is Diagnostic Equipment.

  • Is ENTvantage Dx a private or public company?

    ENTvantage Dx is a Private company.

  • What is ENTvantage Dx’s current revenue?

    The current revenue for ENTvantage Dx is .

  • How much funding has ENTvantage Dx raised over time?

    ENTvantage Dx has raised $6.63M.

  • Who are ENTvantage Dx’s investors?

    HSC Next, Capital Factory, Denniston Family Office, Sea Purity Investments, and National Institutes of Health are 5 of 14 investors who have invested in ENTvantage Dx.

  • Who are ENTvantage Dx’s competitors?

    Q-linea and Neurent Medical are competitors of ENTvantage Dx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »